Viewing Study NCT01399593


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-01-01 @ 10:46 AM
Study NCT ID: NCT01399593
Status: TERMINATED
Last Update Posted: 2017-10-03
First Post: 2011-07-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Sponsor: Alexion Pharmaceuticals, Inc.
Organization: